BioSpace News Archive

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, has been made aware of a lawsuit filed by Endovalve Inc. and Micro Interventional Devices, Inc

Vineti’s leading digital “platform of record” for next-generation therapies, integrating with World Courier’s global specialty logistics solution, supports commercial- and clinical-phase personalized medicines world-wide.

Astanza Laser recently added Beth Gualario to their rapidly expanding sales team as the Regional Sales Manager in Florida.

AusCann begins trading today on OTCQX under the symbol “ACNNF.”

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary biosynthesis platform technology to develop novel therapeutics for the treatment of diseases with high unmet medical needs, today announced that the Company’s research partner, University of British Columbia (“UBC”), has been approved to receive a grant from the Natural Sciences and Engineering Research

Dr. Brenner will serve on the executive leadership team and report to Codiak’s president and CEO, Douglas E. Williams, Ph.D.

DSUVIA Advisory Committee meeting date set for October 12, 2018

Research by Milken Institute and Depression and Bipolar Support Alliance is designed to yield patient input to guide research and treatment; Early results suggest pre-adolescent treatment may be needed

Casma Therapeutics, Inc. today announced a research collaboration with Fondazione Telethon, founder of the Telethon Institute of Genetics and Medicine (TIGEM), to develop new therapies for lysosomal storage disorders and more common disorders such as neurodegeneration.

Hearthside Home Care awarded FirstLight Home Care franchise, becomes first conversion in franchise system